nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP3A4—bone cancer	0.861	1	CbGaD
Dolasetron—Polyuria—Methotrexate—bone cancer	0.000584	0.00421	CcSEcCtD
Dolasetron—Arrhythmia—Cisplatin—bone cancer	0.000578	0.00416	CcSEcCtD
Dolasetron—Abnormal vision—Epirubicin—bone cancer	0.000577	0.00415	CcSEcCtD
Dolasetron—Aplastic anaemia—Doxorubicin—bone cancer	0.000575	0.00414	CcSEcCtD
Dolasetron—Sepsis—Epirubicin—bone cancer	0.000574	0.00413	CcSEcCtD
Dolasetron—Phlebitis—Epirubicin—bone cancer	0.000557	0.00401	CcSEcCtD
Dolasetron—Renal failure acute—Methotrexate—bone cancer	0.000556	0.004	CcSEcCtD
Dolasetron—Flatulence—Cisplatin—bone cancer	0.000555	0.00399	CcSEcCtD
Dolasetron—Thrombophlebitis—Epirubicin—bone cancer	0.000555	0.00399	CcSEcCtD
Dolasetron—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.000552	0.00397	CcSEcCtD
Dolasetron—Hepatic function abnormal—Epirubicin—bone cancer	0.00055	0.00396	CcSEcCtD
Dolasetron—Vascular purpura—Epirubicin—bone cancer	0.000537	0.00386	CcSEcCtD
Dolasetron—Abnormal vision—Doxorubicin—bone cancer	0.000534	0.00384	CcSEcCtD
Dolasetron—Sepsis—Doxorubicin—bone cancer	0.000531	0.00382	CcSEcCtD
Dolasetron—Anaphylactoid reaction—Methotrexate—bone cancer	0.00053	0.00382	CcSEcCtD
Dolasetron—Tremor—Cisplatin—bone cancer	0.000528	0.0038	CcSEcCtD
Dolasetron—Ill-defined disorder—Cisplatin—bone cancer	0.000523	0.00376	CcSEcCtD
Dolasetron—Anaemia—Cisplatin—bone cancer	0.000521	0.00375	CcSEcCtD
Dolasetron—Renal failure acute—Epirubicin—bone cancer	0.00052	0.00374	CcSEcCtD
Dolasetron—Phlebitis—Doxorubicin—bone cancer	0.000516	0.00371	CcSEcCtD
Dolasetron—Thrombophlebitis—Doxorubicin—bone cancer	0.000513	0.00369	CcSEcCtD
Dolasetron—Increased appetite—Epirubicin—bone cancer	0.000511	0.00368	CcSEcCtD
Dolasetron—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.000511	0.00368	CcSEcCtD
Dolasetron—Hepatic function abnormal—Doxorubicin—bone cancer	0.000508	0.00366	CcSEcCtD
Dolasetron—Malaise—Cisplatin—bone cancer	0.000508	0.00366	CcSEcCtD
Dolasetron—Purpura—Epirubicin—bone cancer	0.000498	0.00359	CcSEcCtD
Dolasetron—Vascular purpura—Doxorubicin—bone cancer	0.000497	0.00358	CcSEcCtD
Dolasetron—Anaphylactoid reaction—Epirubicin—bone cancer	0.000496	0.00357	CcSEcCtD
Dolasetron—Convulsion—Cisplatin—bone cancer	0.000488	0.00351	CcSEcCtD
Dolasetron—Ataxia—Methotrexate—bone cancer	0.000483	0.00347	CcSEcCtD
Dolasetron—Renal failure acute—Doxorubicin—bone cancer	0.000481	0.00346	CcSEcCtD
Dolasetron—Myalgia—Cisplatin—bone cancer	0.00048	0.00345	CcSEcCtD
Dolasetron—Anxiety—Cisplatin—bone cancer	0.000478	0.00344	CcSEcCtD
Dolasetron—Discomfort—Cisplatin—bone cancer	0.000474	0.00341	CcSEcCtD
Dolasetron—Increased appetite—Doxorubicin—bone cancer	0.000473	0.0034	CcSEcCtD
Dolasetron—Face oedema—Epirubicin—bone cancer	0.000464	0.00334	CcSEcCtD
Dolasetron—Purpura—Doxorubicin—bone cancer	0.000461	0.00332	CcSEcCtD
Dolasetron—Oedema—Cisplatin—bone cancer	0.00046	0.00331	CcSEcCtD
Dolasetron—Anaphylactic shock—Cisplatin—bone cancer	0.00046	0.00331	CcSEcCtD
Dolasetron—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000459	0.0033	CcSEcCtD
Dolasetron—Cardiac arrest—Epirubicin—bone cancer	0.000457	0.00329	CcSEcCtD
Dolasetron—Ataxia—Epirubicin—bone cancer	0.000452	0.00325	CcSEcCtD
Dolasetron—Thrombocytopenia—Cisplatin—bone cancer	0.00045	0.00324	CcSEcCtD
Dolasetron—Tachycardia—Cisplatin—bone cancer	0.000449	0.00323	CcSEcCtD
Dolasetron—Dehydration—Epirubicin—bone cancer	0.000447	0.00321	CcSEcCtD
Dolasetron—Hyperhidrosis—Cisplatin—bone cancer	0.000444	0.0032	CcSEcCtD
Dolasetron—Orthostatic hypotension—Epirubicin—bone cancer	0.000439	0.00316	CcSEcCtD
Dolasetron—Anorexia—Cisplatin—bone cancer	0.000438	0.00315	CcSEcCtD
Dolasetron—Pancreatitis—Methotrexate—bone cancer	0.000435	0.00313	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000432	0.00311	CcSEcCtD
Dolasetron—Hypotension—Cisplatin—bone cancer	0.00043	0.00309	CcSEcCtD
Dolasetron—Face oedema—Doxorubicin—bone cancer	0.000429	0.00309	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000424	0.00305	CcSEcCtD
Dolasetron—Cardiac arrest—Doxorubicin—bone cancer	0.000423	0.00304	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000419	0.00301	CcSEcCtD
Dolasetron—Abdominal distension—Epirubicin—bone cancer	0.000418	0.00301	CcSEcCtD
Dolasetron—Ataxia—Doxorubicin—bone cancer	0.000418	0.00301	CcSEcCtD
Dolasetron—Dysuria—Methotrexate—bone cancer	0.000415	0.00299	CcSEcCtD
Dolasetron—Dehydration—Doxorubicin—bone cancer	0.000413	0.00297	CcSEcCtD
Dolasetron—Paraesthesia—Cisplatin—bone cancer	0.000413	0.00297	CcSEcCtD
Dolasetron—Dyspnoea—Cisplatin—bone cancer	0.00041	0.00295	CcSEcCtD
Dolasetron—Pancreatitis—Epirubicin—bone cancer	0.000407	0.00293	CcSEcCtD
Dolasetron—Orthostatic hypotension—Doxorubicin—bone cancer	0.000406	0.00292	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.0004	0.00288	CcSEcCtD
Dolasetron—Decreased appetite—Cisplatin—bone cancer	0.0004	0.00288	CcSEcCtD
Dolasetron—Pneumonia—Methotrexate—bone cancer	0.000398	0.00286	CcSEcCtD
Dolasetron—Drowsiness—Methotrexate—bone cancer	0.000395	0.00285	CcSEcCtD
Dolasetron—Pain—Cisplatin—bone cancer	0.000393	0.00283	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000392	0.00282	CcSEcCtD
Dolasetron—Dysuria—Epirubicin—bone cancer	0.000388	0.00279	CcSEcCtD
Dolasetron—Abdominal distension—Doxorubicin—bone cancer	0.000387	0.00278	CcSEcCtD
Dolasetron—Stomatitis—Methotrexate—bone cancer	0.000386	0.00277	CcSEcCtD
Dolasetron—Feeling abnormal—Cisplatin—bone cancer	0.000379	0.00273	CcSEcCtD
Dolasetron—Haematuria—Methotrexate—bone cancer	0.000377	0.00271	CcSEcCtD
Dolasetron—Pancreatitis—Doxorubicin—bone cancer	0.000377	0.00271	CcSEcCtD
Dolasetron—Epistaxis—Methotrexate—bone cancer	0.000373	0.00268	CcSEcCtD
Dolasetron—Pneumonia—Epirubicin—bone cancer	0.000372	0.00268	CcSEcCtD
Dolasetron—Drowsiness—Epirubicin—bone cancer	0.00037	0.00266	CcSEcCtD
Dolasetron—Body temperature increased—Cisplatin—bone cancer	0.000363	0.00262	CcSEcCtD
Dolasetron—Stomatitis—Epirubicin—bone cancer	0.000361	0.0026	CcSEcCtD
Dolasetron—Jaundice—Epirubicin—bone cancer	0.000361	0.0026	CcSEcCtD
Dolasetron—Dysuria—Doxorubicin—bone cancer	0.000359	0.00258	CcSEcCtD
Dolasetron—Haematuria—Epirubicin—bone cancer	0.000353	0.00254	CcSEcCtD
Dolasetron—Epistaxis—Epirubicin—bone cancer	0.000349	0.00251	CcSEcCtD
Dolasetron—Pneumonia—Doxorubicin—bone cancer	0.000344	0.00248	CcSEcCtD
Dolasetron—Drowsiness—Doxorubicin—bone cancer	0.000342	0.00246	CcSEcCtD
Dolasetron—Visual impairment—Methotrexate—bone cancer	0.000342	0.00246	CcSEcCtD
Dolasetron—Hypersensitivity—Cisplatin—bone cancer	0.000339	0.00244	CcSEcCtD
Dolasetron—Bradycardia—Epirubicin—bone cancer	0.000338	0.00243	CcSEcCtD
Dolasetron—Jaundice—Doxorubicin—bone cancer	0.000334	0.0024	CcSEcCtD
Dolasetron—Stomatitis—Doxorubicin—bone cancer	0.000334	0.0024	CcSEcCtD
Dolasetron—Tinnitus—Methotrexate—bone cancer	0.000331	0.00238	CcSEcCtD
Dolasetron—Asthenia—Cisplatin—bone cancer	0.00033	0.00237	CcSEcCtD
Dolasetron—Oedema peripheral—Epirubicin—bone cancer	0.000327	0.00236	CcSEcCtD
Dolasetron—Haematuria—Doxorubicin—bone cancer	0.000327	0.00235	CcSEcCtD
Dolasetron—Epistaxis—Doxorubicin—bone cancer	0.000323	0.00232	CcSEcCtD
Dolasetron—Visual impairment—Epirubicin—bone cancer	0.00032	0.0023	CcSEcCtD
Dolasetron—Chills—Methotrexate—bone cancer	0.000319	0.00229	CcSEcCtD
Dolasetron—Diarrhoea—Cisplatin—bone cancer	0.000315	0.00226	CcSEcCtD
Dolasetron—Bradycardia—Doxorubicin—bone cancer	0.000313	0.00225	CcSEcCtD
Dolasetron—Tinnitus—Epirubicin—bone cancer	0.00031	0.00223	CcSEcCtD
Dolasetron—Flushing—Epirubicin—bone cancer	0.000308	0.00222	CcSEcCtD
Dolasetron—Oedema peripheral—Doxorubicin—bone cancer	0.000303	0.00218	CcSEcCtD
Dolasetron—Dysgeusia—Methotrexate—bone cancer	0.000303	0.00218	CcSEcCtD
Dolasetron—Chills—Epirubicin—bone cancer	0.000298	0.00215	CcSEcCtD
Dolasetron—Arrhythmia—Epirubicin—bone cancer	0.000297	0.00214	CcSEcCtD
Dolasetron—Visual impairment—Doxorubicin—bone cancer	0.000296	0.00213	CcSEcCtD
Dolasetron—Rash—Cisplatin—bone cancer	0.00029	0.00209	CcSEcCtD
Dolasetron—Dermatitis—Cisplatin—bone cancer	0.00029	0.00208	CcSEcCtD
Dolasetron—Ill-defined disorder—Methotrexate—bone cancer	0.000287	0.00206	CcSEcCtD
Dolasetron—Tinnitus—Doxorubicin—bone cancer	0.000287	0.00206	CcSEcCtD
Dolasetron—Anaemia—Methotrexate—bone cancer	0.000286	0.00206	CcSEcCtD
Dolasetron—Flushing—Doxorubicin—bone cancer	0.000285	0.00205	CcSEcCtD
Dolasetron—Flatulence—Epirubicin—bone cancer	0.000285	0.00205	CcSEcCtD
Dolasetron—Dysgeusia—Epirubicin—bone cancer	0.000283	0.00204	CcSEcCtD
Dolasetron—Malaise—Methotrexate—bone cancer	0.000279	0.00201	CcSEcCtD
Dolasetron—Vertigo—Methotrexate—bone cancer	0.000278	0.002	CcSEcCtD
Dolasetron—Chills—Doxorubicin—bone cancer	0.000276	0.00199	CcSEcCtD
Dolasetron—Arrhythmia—Doxorubicin—bone cancer	0.000275	0.00198	CcSEcCtD
Dolasetron—Cough—Methotrexate—bone cancer	0.00027	0.00194	CcSEcCtD
Dolasetron—Ill-defined disorder—Epirubicin—bone cancer	0.000268	0.00193	CcSEcCtD
Dolasetron—Convulsion—Methotrexate—bone cancer	0.000268	0.00193	CcSEcCtD
Dolasetron—Anaemia—Epirubicin—bone cancer	0.000267	0.00192	CcSEcCtD
Dolasetron—Agitation—Epirubicin—bone cancer	0.000266	0.00191	CcSEcCtD
Dolasetron—Flatulence—Doxorubicin—bone cancer	0.000264	0.0019	CcSEcCtD
Dolasetron—Arthralgia—Methotrexate—bone cancer	0.000263	0.00189	CcSEcCtD
Dolasetron—Chest pain—Methotrexate—bone cancer	0.000263	0.00189	CcSEcCtD
Dolasetron—Myalgia—Methotrexate—bone cancer	0.000263	0.00189	CcSEcCtD
Dolasetron—Dysgeusia—Doxorubicin—bone cancer	0.000262	0.00189	CcSEcCtD
Dolasetron—Malaise—Epirubicin—bone cancer	0.000261	0.00188	CcSEcCtD
Dolasetron—Discomfort—Methotrexate—bone cancer	0.00026	0.00187	CcSEcCtD
Dolasetron—Vertigo—Epirubicin—bone cancer	0.00026	0.00187	CcSEcCtD
Dolasetron—Syncope—Epirubicin—bone cancer	0.000259	0.00187	CcSEcCtD
Dolasetron—Palpitations—Epirubicin—bone cancer	0.000256	0.00184	CcSEcCtD
Dolasetron—Confusional state—Methotrexate—bone cancer	0.000254	0.00183	CcSEcCtD
Dolasetron—Loss of consciousness—Epirubicin—bone cancer	0.000254	0.00183	CcSEcCtD
Dolasetron—Cough—Epirubicin—bone cancer	0.000252	0.00182	CcSEcCtD
Dolasetron—Anaphylactic shock—Methotrexate—bone cancer	0.000252	0.00182	CcSEcCtD
Dolasetron—Convulsion—Epirubicin—bone cancer	0.000251	0.0018	CcSEcCtD
Dolasetron—Hypertension—Epirubicin—bone cancer	0.00025	0.0018	CcSEcCtD
Dolasetron—Ill-defined disorder—Doxorubicin—bone cancer	0.000248	0.00179	CcSEcCtD
Dolasetron—Anaemia—Doxorubicin—bone cancer	0.000247	0.00178	CcSEcCtD
Dolasetron—Thrombocytopenia—Methotrexate—bone cancer	0.000247	0.00178	CcSEcCtD
Dolasetron—Arthralgia—Epirubicin—bone cancer	0.000246	0.00177	CcSEcCtD
Dolasetron—Chest pain—Epirubicin—bone cancer	0.000246	0.00177	CcSEcCtD
Dolasetron—Myalgia—Epirubicin—bone cancer	0.000246	0.00177	CcSEcCtD
Dolasetron—Agitation—Doxorubicin—bone cancer	0.000246	0.00177	CcSEcCtD
Dolasetron—Anxiety—Epirubicin—bone cancer	0.000245	0.00177	CcSEcCtD
Dolasetron—Hyperhidrosis—Methotrexate—bone cancer	0.000244	0.00176	CcSEcCtD
Dolasetron—Discomfort—Epirubicin—bone cancer	0.000243	0.00175	CcSEcCtD
Dolasetron—Malaise—Doxorubicin—bone cancer	0.000241	0.00174	CcSEcCtD
Dolasetron—Dry mouth—Epirubicin—bone cancer	0.000241	0.00173	CcSEcCtD
Dolasetron—Vertigo—Doxorubicin—bone cancer	0.00024	0.00173	CcSEcCtD
Dolasetron—Anorexia—Methotrexate—bone cancer	0.00024	0.00173	CcSEcCtD
Dolasetron—Syncope—Doxorubicin—bone cancer	0.00024	0.00173	CcSEcCtD
Dolasetron—Confusional state—Epirubicin—bone cancer	0.000238	0.00171	CcSEcCtD
Dolasetron—Palpitations—Doxorubicin—bone cancer	0.000237	0.0017	CcSEcCtD
Dolasetron—Oedema—Epirubicin—bone cancer	0.000236	0.0017	CcSEcCtD
Dolasetron—Anaphylactic shock—Epirubicin—bone cancer	0.000236	0.0017	CcSEcCtD
Dolasetron—Hypotension—Methotrexate—bone cancer	0.000236	0.0017	CcSEcCtD
Dolasetron—Loss of consciousness—Doxorubicin—bone cancer	0.000235	0.00169	CcSEcCtD
Dolasetron—Cough—Doxorubicin—bone cancer	0.000234	0.00168	CcSEcCtD
Dolasetron—Shock—Epirubicin—bone cancer	0.000232	0.00167	CcSEcCtD
Dolasetron—Convulsion—Doxorubicin—bone cancer	0.000232	0.00167	CcSEcCtD
Dolasetron—Thrombocytopenia—Epirubicin—bone cancer	0.000231	0.00166	CcSEcCtD
Dolasetron—Hypertension—Doxorubicin—bone cancer	0.000231	0.00166	CcSEcCtD
Dolasetron—Tachycardia—Epirubicin—bone cancer	0.00023	0.00166	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00023	0.00165	CcSEcCtD
Dolasetron—Hyperhidrosis—Epirubicin—bone cancer	0.000228	0.00164	CcSEcCtD
Dolasetron—Arthralgia—Doxorubicin—bone cancer	0.000228	0.00164	CcSEcCtD
Dolasetron—Chest pain—Doxorubicin—bone cancer	0.000228	0.00164	CcSEcCtD
Dolasetron—Myalgia—Doxorubicin—bone cancer	0.000228	0.00164	CcSEcCtD
Dolasetron—Anxiety—Doxorubicin—bone cancer	0.000227	0.00163	CcSEcCtD
Dolasetron—Paraesthesia—Methotrexate—bone cancer	0.000227	0.00163	CcSEcCtD
Dolasetron—Discomfort—Doxorubicin—bone cancer	0.000225	0.00162	CcSEcCtD
Dolasetron—Anorexia—Epirubicin—bone cancer	0.000225	0.00162	CcSEcCtD
Dolasetron—Dyspnoea—Methotrexate—bone cancer	0.000225	0.00162	CcSEcCtD
Dolasetron—Somnolence—Methotrexate—bone cancer	0.000224	0.00161	CcSEcCtD
Dolasetron—Dry mouth—Doxorubicin—bone cancer	0.000223	0.0016	CcSEcCtD
Dolasetron—Dyspepsia—Methotrexate—bone cancer	0.000222	0.0016	CcSEcCtD
Dolasetron—Hypotension—Epirubicin—bone cancer	0.000221	0.00159	CcSEcCtD
Dolasetron—Confusional state—Doxorubicin—bone cancer	0.00022	0.00159	CcSEcCtD
Dolasetron—Decreased appetite—Methotrexate—bone cancer	0.000219	0.00158	CcSEcCtD
Dolasetron—Anaphylactic shock—Doxorubicin—bone cancer	0.000218	0.00157	CcSEcCtD
Dolasetron—Oedema—Doxorubicin—bone cancer	0.000218	0.00157	CcSEcCtD
Dolasetron—Fatigue—Methotrexate—bone cancer	0.000217	0.00157	CcSEcCtD
Dolasetron—Pain—Methotrexate—bone cancer	0.000216	0.00155	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000215	0.00155	CcSEcCtD
Dolasetron—Shock—Doxorubicin—bone cancer	0.000215	0.00155	CcSEcCtD
Dolasetron—Thrombocytopenia—Doxorubicin—bone cancer	0.000214	0.00154	CcSEcCtD
Dolasetron—Tachycardia—Doxorubicin—bone cancer	0.000213	0.00153	CcSEcCtD
Dolasetron—Paraesthesia—Epirubicin—bone cancer	0.000212	0.00153	CcSEcCtD
Dolasetron—Hyperhidrosis—Doxorubicin—bone cancer	0.000211	0.00152	CcSEcCtD
Dolasetron—Dyspnoea—Epirubicin—bone cancer	0.00021	0.00151	CcSEcCtD
Dolasetron—Somnolence—Epirubicin—bone cancer	0.00021	0.00151	CcSEcCtD
Dolasetron—Anorexia—Doxorubicin—bone cancer	0.000208	0.0015	CcSEcCtD
Dolasetron—Feeling abnormal—Methotrexate—bone cancer	0.000208	0.0015	CcSEcCtD
Dolasetron—Dyspepsia—Epirubicin—bone cancer	0.000208	0.0015	CcSEcCtD
Dolasetron—Gastrointestinal pain—Methotrexate—bone cancer	0.000206	0.00148	CcSEcCtD
Dolasetron—Decreased appetite—Epirubicin—bone cancer	0.000205	0.00148	CcSEcCtD
Dolasetron—Hypotension—Doxorubicin—bone cancer	0.000204	0.00147	CcSEcCtD
Dolasetron—Fatigue—Epirubicin—bone cancer	0.000204	0.00146	CcSEcCtD
Dolasetron—Pain—Epirubicin—bone cancer	0.000202	0.00145	CcSEcCtD
Dolasetron—Constipation—Epirubicin—bone cancer	0.000202	0.00145	CcSEcCtD
Dolasetron—Urticaria—Methotrexate—bone cancer	0.0002	0.00144	CcSEcCtD
Dolasetron—Abdominal pain—Methotrexate—bone cancer	0.000199	0.00144	CcSEcCtD
Dolasetron—Body temperature increased—Methotrexate—bone cancer	0.000199	0.00144	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000199	0.00143	CcSEcCtD
Dolasetron—Paraesthesia—Doxorubicin—bone cancer	0.000196	0.00141	CcSEcCtD
Dolasetron—Dyspnoea—Doxorubicin—bone cancer	0.000195	0.0014	CcSEcCtD
Dolasetron—Feeling abnormal—Epirubicin—bone cancer	0.000195	0.0014	CcSEcCtD
Dolasetron—Somnolence—Doxorubicin—bone cancer	0.000194	0.0014	CcSEcCtD
Dolasetron—Gastrointestinal pain—Epirubicin—bone cancer	0.000193	0.00139	CcSEcCtD
Dolasetron—Dyspepsia—Doxorubicin—bone cancer	0.000192	0.00138	CcSEcCtD
Dolasetron—Decreased appetite—Doxorubicin—bone cancer	0.00019	0.00137	CcSEcCtD
Dolasetron—Fatigue—Doxorubicin—bone cancer	0.000188	0.00136	CcSEcCtD
Dolasetron—Urticaria—Epirubicin—bone cancer	0.000188	0.00135	CcSEcCtD
Dolasetron—Pain—Doxorubicin—bone cancer	0.000187	0.00134	CcSEcCtD
Dolasetron—Constipation—Doxorubicin—bone cancer	0.000187	0.00134	CcSEcCtD
Dolasetron—Abdominal pain—Epirubicin—bone cancer	0.000187	0.00134	CcSEcCtD
Dolasetron—Body temperature increased—Epirubicin—bone cancer	0.000187	0.00134	CcSEcCtD
Dolasetron—Hypersensitivity—Methotrexate—bone cancer	0.000186	0.00134	CcSEcCtD
Dolasetron—Asthenia—Methotrexate—bone cancer	0.000181	0.0013	CcSEcCtD
Dolasetron—Feeling abnormal—Doxorubicin—bone cancer	0.00018	0.0013	CcSEcCtD
Dolasetron—Gastrointestinal pain—Doxorubicin—bone cancer	0.000179	0.00129	CcSEcCtD
Dolasetron—Pruritus—Methotrexate—bone cancer	0.000178	0.00128	CcSEcCtD
Dolasetron—Hypersensitivity—Epirubicin—bone cancer	0.000174	0.00125	CcSEcCtD
Dolasetron—Urticaria—Doxorubicin—bone cancer	0.000174	0.00125	CcSEcCtD
Dolasetron—Abdominal pain—Doxorubicin—bone cancer	0.000173	0.00124	CcSEcCtD
Dolasetron—Body temperature increased—Doxorubicin—bone cancer	0.000173	0.00124	CcSEcCtD
Dolasetron—Diarrhoea—Methotrexate—bone cancer	0.000173	0.00124	CcSEcCtD
Dolasetron—Asthenia—Epirubicin—bone cancer	0.000169	0.00122	CcSEcCtD
Dolasetron—Pruritus—Epirubicin—bone cancer	0.000167	0.0012	CcSEcCtD
Dolasetron—Dizziness—Methotrexate—bone cancer	0.000167	0.0012	CcSEcCtD
Dolasetron—Diarrhoea—Epirubicin—bone cancer	0.000162	0.00116	CcSEcCtD
Dolasetron—Hypersensitivity—Doxorubicin—bone cancer	0.000161	0.00116	CcSEcCtD
Dolasetron—Rash—Methotrexate—bone cancer	0.000159	0.00114	CcSEcCtD
Dolasetron—Dermatitis—Methotrexate—bone cancer	0.000159	0.00114	CcSEcCtD
Dolasetron—Headache—Methotrexate—bone cancer	0.000158	0.00114	CcSEcCtD
Dolasetron—Asthenia—Doxorubicin—bone cancer	0.000157	0.00113	CcSEcCtD
Dolasetron—Dizziness—Epirubicin—bone cancer	0.000156	0.00112	CcSEcCtD
Dolasetron—Pruritus—Doxorubicin—bone cancer	0.000155	0.00111	CcSEcCtD
Dolasetron—Diarrhoea—Doxorubicin—bone cancer	0.000149	0.00108	CcSEcCtD
Dolasetron—Rash—Epirubicin—bone cancer	0.000149	0.00107	CcSEcCtD
Dolasetron—Dermatitis—Epirubicin—bone cancer	0.000149	0.00107	CcSEcCtD
Dolasetron—Headache—Epirubicin—bone cancer	0.000148	0.00106	CcSEcCtD
Dolasetron—Dizziness—Doxorubicin—bone cancer	0.000144	0.00104	CcSEcCtD
Dolasetron—Rash—Doxorubicin—bone cancer	0.000138	0.000991	CcSEcCtD
Dolasetron—Dermatitis—Doxorubicin—bone cancer	0.000138	0.00099	CcSEcCtD
Dolasetron—Headache—Doxorubicin—bone cancer	0.000137	0.000985	CcSEcCtD
